Multimodal Noninvasive Assessment of Peripheral Circulation in Chronic Limb-threatening Ischemia

Sponsor
Tampere University (Other)
Overall Status
Enrolling by invitation
CT.gov ID
NCT05786001
Collaborator
Tampere University Hospital (Other)
150
1
10.1
14.9

Study Details

Study Description

Brief Summary

Assessment of a novel diagnostic method for screening and diagnosing chronic limb-threatening ischemia (CLTI). Using hyperspectral and thermal imaging, the perfusion and oxygenation in the lower limbs will be studied in healthy and unhealthy individuals.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    150 participants
    Observational Model:
    Case-Control
    Time Perspective:
    Cross-Sectional
    Official Title:
    Evaluation of Lower Limb Angiosome Perfusion and Oxygenation Using Thermal and Hyperspectral Imaging
    Anticipated Study Start Date :
    Apr 1, 2023
    Anticipated Primary Completion Date :
    Apr 30, 2023
    Anticipated Study Completion Date :
    Feb 1, 2024

    Arms and Interventions

    Arm Intervention/Treatment
    Unhealthy group

    Individuals with CLTI

    Age control group

    Healthy individuals over the age of 50

    Healthy group

    Healthy and young individuals

    Outcome Measures

    Primary Outcome Measures

    1. Perfusion in lower limb angiosomes assessed by thermal imaging [45 minutes during the procedure starting from the first measurement and ending after the last measurement]

      Thermal imaging will be used to assess the perfusion in the lower limbs. The lower limb can be divided into six angiosomes, which can then be used to assess thermal patterns. Healthy and unhealthy feet will present with different thermal patterns and other changes in thermographs.

    2. Oxygenation in lower limb angiosomes assessed by hyperspectral imaging. [45 minutes during the procedure starting from the first measurement and ending after the last measurement]

      Hyperspectral imaging can be used in the assessment of oxygenation in the lower limb angiosomes. Based on hyperspectral imaging, oxygenation maps can be generated and then analyzed. Differences between the oxygenation maps of healthy and unhealthy patients will be established.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • for CLTI patients age >50

    • for age control group age >50 and not diagnosed with cardiovascular diseases. 0.9 < ABI < 1.3

    • for healthy group 18 <= age <= 50 and no history of cardiovascular disease

    • volunteering for study

    Exclusion Criteria:
    • inability to give informed consent

    • denial

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Tampere University Tampere Pirkanmaa Finland 33720

    Sponsors and Collaborators

    • Tampere University
    • Tampere University Hospital

    Investigators

    • Principal Investigator: Niku Oksala, MD, PhD, DSc, Tampere University, Tampere University Hospital

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Niku Oksala, Prof, MD, PhD, DSc, Tampere University
    ClinicalTrials.gov Identifier:
    NCT05786001
    Other Study ID Numbers:
    • R20156L
    First Posted:
    Mar 27, 2023
    Last Update Posted:
    Mar 27, 2023
    Last Verified:
    Mar 1, 2023
    Studies a U.S. FDA-regulated Drug Product:
    No
    Keywords provided by Niku Oksala, Prof, MD, PhD, DSc, Tampere University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Mar 27, 2023